Evidence map›Paper›PMID 40735035›Full record

ArticleFrontiers in oncology2025

Deep learning-based multi-omics model to predict nasopharyngeal necrosis of re-irradiation for recurrent nasopharyngeal carcinoma.

Xingwang Gao, Yinglin Peng, Shanfu Lu, Yuhan An, Meining Chen, Jun Zhang, Runda Huang, Yiran Wang, Zhenyu Qi, Yao Lu and 4 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xingwang Gao *Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yinglin Peng *Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Shanfu Lu *Perception Vision Medical Technologies Co. Ltd., Guangzhou, China.
Yuhan AnDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Meining ChenDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Jun ZhangDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Runda HuangDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yiran WangSchool of Data and Computer Science, Sun Yat-sen University, Guangzhou, China.
Zhenyu QiDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yao LuSchool of Data and Computer Science, Sun Yat-sen University, Guangzhou, China.
Chong ZhaoDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Xiaowu DengDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Jingjing MiaoDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yimei LiuDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Patients with recurrent nasopharyngeal carcinoma (rNPC) undergoing re-irradiation have a high risk of lethal nasopharyngeal necrosis (NN), which may lead to massive nasopharyngeal hemorrhage or death. Predicting NN is crucial to improve the prognosis of these patients. We aimed to utilize deep learning techniques in combination with multi-sequence magnetic resonance imaging (MRI) radiomics and dosiomics to predict the risk of nasopharyngeal necrosis in patients with recurrent nasopharyngeal carcinoma undergoing re-irradiation therapy. Materials and methods: 117 patients with rNPC were included, comprising pre-treatment multi-sequence MR images (including T1, T1C, and T2 sequences) and a planned re-irradiation therapy dose distribution. A three-dimensional (3D) convolutional neural network (CNN) deep learning network model was utilized to integrate the selected MRI radiomics and dosiomics features. Eight prediction deep learning models were developed for training, 97 cases were used as the training set and 20 as the test set. The performance and prediction accuracy of each deep learning network model were then evaluated. Results: Thirty-two features correlated with necrosis of rNPC. The model based on multi-sequence MRI radiomics could better predict necrosis. The models combining radiomics and dosiomics features were more accurate for the prediction of NN, especially the model of multi-sequence MRI radiomics plus dosiomics, which showed the best performance in the test set, with an AUC, ACC, and F1-Score of 0.81, 0.75, and 0.74, respectively. Conclusion: The deep learning model leveraging pre-treatment multi-sequence MRI radiomics and dosiomics of re-irradiation therapy can serve as a potential predictor of NN in patients with recurrent nasopharyngeal carcinoma, thereby improving clinical decision-making processes.

Indexed as

deep learningmagnetic resonance imagingnasopharyngeal necrosisradiation therapyrecurrent nasopharyngeal carcinoma

Identifiers

PMID40735035
PMCPMC12303931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.